secwatch.observer — SEC 8-K summary
======================================

Issuer:     QUEST DIAGNOSTICS INC (DGX)
CIK:        0001022079
Form:       8-K
Filed at:   2022-04-21T23:59:59+00:00
Accession:  0001022079-22-000071
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Quest Diagnostics raises FY2022 guidance after Q1 base business grows 6.3%; adjusted EPS $3.22
--------------------------------------------------------------------------------

- Q1 net revenues $2.61B (-4.0% YoY); base business revenues $2.01B (+6.3% YoY); COVID revenues $599M (-27.6%).
- Reported diluted EPS $2.92 (-15.6%); adjusted diluted EPS $3.22 (-14.4%).
- Full year 2022 guidance raised: reported EPS $7.88-$8.38; adjusted EPS $9.00-$9.50; revenues $9.2B-$9.5B.
- Cash from operations $480M (-34.2%); capex $63M (-26.7%).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1022079/000102207922000071/0001022079-22-000071-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1022079/000102207922000071/dgx-20220421.htm
  HTML page:      https://secwatch.observer/filing/0001022079-22-000071

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer